Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables - Other: 2014-2025

Historic Receivables - Other for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $2.0 million.

  • AC Immune's Receivables - Other rose 97.17% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 97.17%. This contributed to the annual value of $2.0 million for FY2025, which is N/A change from last year.
  • AC Immune's Receivables - Other amounted to $2.0 million in Q3 2025, which was up 100,902.43% from $1,958 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Receivables - Other registered a high of $419.2 million during Q1 2021, and its lowest value of -$3.9 million during Q3 2022.
  • Its 3-year average for Receivables - Other is $873,529, with a median of $701,215 in 2023.
  • As far as peak fluctuations go, AC Immune's Receivables - Other skyrocketed by 164,258.89% in 2021, and later crashed by 32,760.33% in 2022.
  • AC Immune's Receivables - Other (Quarterly) stood at $464,167 in 2021, then decreased by 12.34% to $406,905 in 2022, then surged by 72.33% to $701,215 in 2023, then tumbled by 99.82% to $1,260 in 2024, then soared by 97.17% to $2.0 million in 2025.
  • Its Receivables - Other was $2.0 million in Q3 2025, compared to $1,958 in Q2 2025 and $2.2 million in Q1 2025.